INS and obesity disorder: Further limitations include the minimal number of individuals with isolated IFG in the analysis and also the difference in observed BMI between the NGT and glucose-intolerant groups, thus identifying the impact of increasing obesity on both insulin sensitivity and insulin secretion across the entire glycaemic continuum is difficult.